复宏汉霖(02696)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02696 复宏汉霖

未开盘 02-04 16:08:25

60.100

+1.250

+2.12%

最高60.250	最低56.650	成交量65.76万
今开58.850	昨收58.850	日振幅6.12%
总市值326.64亿	流通市值98.22亿	总股本5.43亿
成交额3,869万	换手率0.40%	流通股本1.63亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02696","market":"HK","secType":"STK","nameCN":"复宏汉霖","latestPrice":60.1,"timestamp":1770192505006,"preClose":58.85,"halted":0,"volume":657600,"delay":0,"changeRate":0.021240441801189464,"floatShares":163428541,"shares":543494853,"eps":1.509618,"marketStatus":"未开盘","change":1.25,"latestTime":"02-04 16:08:25","open":58.85,"high":60.25,"low":56.65,"amount":38693184,"amplitude":0.061172,"askPrice":60.1,"askSize":3000,"bidPrice":60,"bidSize":2700,"shortable":3,"etf":0,"ttmEps":1.661924,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770255000000},"marketStatusCode":0,"adr":0,"listingDate":1569340800000,"exchange":"SEHK","adjPreClose":58.85,"openAndCloseTimeList":[[1770168600000,1770177600000],[1770181200000,1770192000000]],"volumeRatio":0.6862178937493072,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02696","defaultTab":"news","newsList":[{"id":"1117690036","title":"复宏汉霖（02696）更新翌日披露报表，股份变动33.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117690036","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117690036?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:52","pubTimestamp":1770195170,"startTime":"0","endTime":"0","summary":"上海复宏汉霖生物技术股份有限公司（02696）于2026年2月4日发布翌日披露报表，公告显示公司已将182,645,856股非上市股转换为等量H股。\n上述变动占转换前已发行股份总数的33.61%。转换后，H股由原先的163,428,541股增至346,074,397股；同时，非上市股份从380,066,312股降至197,420,456股。\n公司在公告中确认，本次股份变动已通过董事会审批，所有程序符合香港联合交易所有限公司证券上市规则及适用法律法规。\n公告由公司董事Wenjie ZHANG签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02696"],"gpt_icon":0},{"id":"2608359998","title":"复宏汉霖(02696)完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2608359998","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608359998?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:42","pubTimestamp":1770194548,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复宏汉霖(02696)发布公告，合计1.83亿股非上市股已于2026年2月4日完成转换为H股，该等转换H股将于2026年2月5日上午九时正开始于联交所上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","HK0000306685.HKD","HK0000320264.USD","HK0000320223.HKD","HK0000165453.HKD","HK0000306701.USD","02696"],"gpt_icon":0},{"id":"2608437618","title":"港股复宏汉霖早盘涨近5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608437618","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608437618?lang=zh_cn&edition=full","pubTime":"2026-02-03 11:29","pubTimestamp":1770089367,"startTime":"0","endTime":"0","summary":"每经AI快讯，复宏汉霖(02696.HK)早盘涨近5%，截至发稿涨4.1%，报58.4港元，成交额1916.32万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202602033639838021.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602033639838021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","HK0000165453.HKD","HK0000306701.USD","BK4585","VT","HK0000320223.HKD","02696","HK0000306685.HKD","BK1161","HK0000320264.USD"],"gpt_icon":0},{"id":"2608438638","title":"港股异动 | 复宏汉霖(02696)早盘涨近5% HLX22头对头K药胃癌III期临床美国研究者会顺利举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2608438638","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608438638?lang=zh_cn&edition=full","pubTime":"2026-02-03 11:18","pubTimestamp":1770088716,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复宏汉霖(02696)早盘涨近5%，截至发稿，涨4.1%，报58.4港元，成交额1916.32万港元。消息面上，近日，复宏汉霖在美国旧金山顺利举办HLX22-GC-301研究线下研究者会。会议围绕公司在研新表位抗HER2单抗HLX22联合曲妥珠单抗及化疗一线治疗HER2阳性晚期胃癌的国际多中心III期临床研究HLX22-GC-301展开。值得注意的是，复宏汉霖近日宣布，收到国家药监局关于同意注射用HLX43联合HLX07及斯鲁利单抗注射液用于晚期实体瘤治疗开展临床试验的批准。复宏汉霖计划在条件具备后于中国境内开展该联合治疗方案的II期临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1400898.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0211331839.USD","LU2106854487.HKD","LU2360032135.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","LU0980610538.SGD","IE00BLSP4239.USD","LU1093756325.SGD","HK0000165453.HKD","SG9999014559.SGD","LU1116320901.HKD","LU1989772923.USD","IE00BBT3K403.USD","LU0265550359.USD","SG9999015358.SGD","BK4588","LU1571399168.USD","BK4134","LU2461242641.AUD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0203345920.USD","LU1066051811.HKD","IE00BJJMRZ35.SGD","SG9999014542.SGD","LU0965508806.USD","IE00BSNM7G36.USD","LU2361045086.USD","LU2361044949.HKD","LU1934455863.HKD","LU0070302665.USD","LU1037948541.HKD","LU1066051498.USD","LU1934455277.USD","BK4516","LU1037948897.HKD","LU0432979614.USD","LU1934455194.USD","LU1941712264.USD","BK4534","BK4550","LU1699723380.USD","LU0238689110.USD","LU1989772840.SGD","LU0130517989.USD","LU0130102774.USD","SG9999002232.USD","IE00B4R5TH58.HKD","BK4533","LU0106261372.USD","LU0320765489.SGD","LU0861579265.USD","IE00BLSP4452.SGD","LU0648001328.SGD","LU2125154778.USD","SG9999013999.USD","LU1116320737.USD","LU0965509010.AUD","LU0965509283.SGD","SG9999014575.USD","LU1035773651.USD","SG9999015341.SGD","LU2361044865.SGD","IE00BN8TJ469.HKD","LU1023059063.AUD","LU1974910355.USD","SG9999001176.SGD","IE0002141913.USD","SGXZ57979304.SGD","LU0122379950.USD","LU1989771016.USD","HK0000306685.HKD","HK0000320223.HKD","LU0234572021.USD","LU1066053197.SGD","HK0000306701.USD","LU0320765646.SGD","LU0208291251.USD","LU2023250843.SGD","LU2089984988.USD","LU1941712348.USD","HK0000320264.USD","LU1066051225.USD","LU1585245621.USD","LU2125154935.USD","LU0006306889.USD","LU1061106388.HKD","LU1162221912.USD","LU1983299246.USD","LU1057294990.SGD","BK4559","LU1291159041.SGD","02696","LU1917777945.USD","LU2023250504.SGD","LU0098860793.USD","SG9999001440.SGD","LU0985320562.USD","LU0965509101.SGD","BK1161","LU1093756168.USD","LU2112291526.USD","IE0009355771.USD","LU1069347547.HKD","SG9999002224.SGD","BK4007","BK4585","LU0058720904.USD","LU1430594728.SGD","IE00B1BXHZ80.USD","LU2324357040.USD","LU0477156953.USD","LU0266013472.USD","IE000M9KFDE8.USD","LU1201861249.SGD","SG9999001176.USD","LU0265550946.USD","LU1929549753.HKD","LU2468319806.SGD","SG9999014567.USD","LU0203347892.USD"],"gpt_icon":0},{"id":"2608101866","title":"每日卖空追踪 | 复宏汉霖 02月02日卖空量成交6100股，卖空比例为0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608101866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608101866?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:30","pubTimestamp":1770021033,"startTime":"0","endTime":"0","summary":"复宏汉霖北京时间02月02日，跌2.09%，卖空量成交6100股，较上一交易日减少94.36%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163725a6c98673&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163725a6c98673&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320223.HKD","HK0000306701.USD","02696","HK0000165453.HKD","BK1161","HK0000306685.HKD","HK0000320264.USD"],"gpt_icon":0},{"id":"2608850791","title":"复宏汉霖02月02日遭主力抛售345.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608850791","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608850791?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:16","pubTimestamp":1770020165,"startTime":"0","endTime":"0","summary":"02月02日, 复宏汉霖股价跌2.09%，报收56.10元，成交金额5736.1万元，换手率0.63%，振幅4.01%，量比0.83。复宏汉霖今日主力资金净流出345.9万元，上一交易日主力净流出639.9万元。该股近5个交易日上涨0.18%，主力资金累计净流出3007.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出3940.7万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162436a6c97883&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202162436a6c97883&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000306701.USD","02696","HK0000320223.HKD","HK0000320264.USD","HK0000306685.HKD","HK0000165453.HKD"],"gpt_icon":0},{"id":"2607015383","title":"每日卖空追踪 | 复宏汉霖 01月30日卖空量成交5.45万股，卖空比例为8.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607015383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607015383?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:30","pubTimestamp":1769761834,"startTime":"0","endTime":"0","summary":"复宏汉霖北京时间01月30日，跌0.87%，卖空量成交5.45万股，较上一交易日减少81.74%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164104a6bf4e4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130164104a6bf4e4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306701.USD","HK0000320264.USD","HK0000165453.HKD","HK0000306685.HKD","02696","BK1161","HK0000320223.HKD"],"gpt_icon":0},{"id":"2607153590","title":"复宏汉霖01月30日主力净流出639.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607153590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607153590?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:15","pubTimestamp":1769760939,"startTime":"0","endTime":"0","summary":"01月30日, 复宏汉霖股价跌0.87%，报收57.30元，成交金额3594.5万元，换手率0.39%，振幅4.58%，量比0.49。复宏汉霖今日主力资金净流出639.9万元，上一交易日主力净流入36.2万元。该股近5个交易日下跌1.62%，主力资金累计净流出3163.6万元；近20日主力资金累计净流出3858.2万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162053a6bf3635&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130162053a6bf3635&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02696","HK0000165453.HKD","HK0000320223.HKD","HK0000320264.USD","HK0000306701.USD","HK0000306685.HKD","BK1161"],"gpt_icon":0},{"id":"2606688067","title":"港股异动 | 复宏汉霖(02696)早盘涨超4% HLX43联合疗法获国家药监局批准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2606688067","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606688067?lang=zh_cn&edition=full","pubTime":"2026-01-28 10:09","pubTimestamp":1769566151,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，复宏汉霖早盘涨超4%，截至发稿，涨3.48%，报56.5港元，成交额1265.25万港元。消息面上，复宏汉霖宣布，收到国家药监局关于同意注射用HLX43联合HLX07及斯鲁利单抗注射液用于晚期实体瘤治疗开展临床试验的批准。复宏汉霖计划在条件具备后于中国境内开展该联合治疗方案的II期临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1398347.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","HK0000320223.HKD","HK0000306685.HKD","HK0000306701.USD","HK0000320264.USD","BK1161","02696"],"gpt_icon":0},{"id":"2606571847","title":"复宏汉霖境内未上市股份“全流通”获中国证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2606571847","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606571847?lang=zh_cn&edition=full","pubTime":"2026-01-28 09:16","pubTimestamp":1769562983,"startTime":"0","endTime":"0","summary":"南方财经1月28日电，中国证监会国际合作司发布关于上海复宏汉霖生物技术股份有限公司境内未上市股份“全流通”备案通知书，公司17名股东拟将所持合计182,645,856股境内未上市股份转为境外上市股份，并在香港联合交易所上市流通。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601283633088032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02696","HK0000306685.HKD","HK0000165453.HKD","HK0000320223.HKD","BK1161","HK0000320264.USD","HK0000306701.USD"],"gpt_icon":0},{"id":"2606300757","title":"复宏汉霖：HLX43三联疗法获NMPA批准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2606300757","media":"华尔街见闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606300757?lang=zh_cn&edition=full","pubTime":"2026-01-27 19:51","pubTimestamp":1769514672,"startTime":"0","endTime":"0","summary":"复宏汉霖HLX43三联疗法获批临床试验核心要点：获批情况：HLX43（靶向PD-L1抗体偶联药物）联合HLX07（抗EGFR单抗）及汉斯状（斯鲁利单抗）用于晚期实体瘤治疗的临床试验申请获NMPA批准，拟在中国境内开展。HLX43研发进展：在中国、美国、日本等多地开展1期/2期临床试验覆盖NSCLC、结直肠癌、宫颈癌、食管鳞癌等多个适应症临床数据显示：既往治疗失败的NSCLC患者ORR达37.0%，DCR达87.0%；宫颈癌患者ORR达41.4%（3.0mg/kg剂量组达70%）市场地位：全球范围内尚无同类联合用药方案获批上市。风险提示：公司无法确保能成功开发及商业化HLX43及HLX07。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127195401a45c000d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127195401a45c000d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000320223.HKD","HK0000165453.HKD","02696","HK0000306685.HKD","HK0000320264.USD","02196","HK0000306701.USD","BK1191","BK1161","BK1515","BK1593"],"gpt_icon":0},{"id":"1197867551","title":"复宏汉霖注射用HLX43联合HLX07及汉斯状临床试验申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1197867551","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197867551?lang=zh_cn&edition=full","pubTime":"2026-01-27 17:29","pubTimestamp":1769506151,"startTime":"0","endTime":"0","summary":"复宏汉霖（Henlius）宣布，其注射用HLX43联合HLX07及汉斯状（Hansizhuang）的临床试验申请已获得监管机构批准。这一进展标志着公司在创新药物研发领域迈出重要一步，为后续临床研究奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000165453.HKD","HK0000320223.HKD","HK0000306685.HKD","02696","HK0000320264.USD","HK0000306701.USD"],"gpt_icon":0},{"id":"2606202415","title":"复星医药：复宏汉霖及子公司药品临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2606202415","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606202415?lang=zh_cn&edition=full","pubTime":"2026-01-27 17:25","pubTimestamp":1769505958,"startTime":"0","endTime":"0","summary":"1月27日，复星医药（600196/02196）发布公告，公司的控股子公司复宏汉霖（02696）及其控股子公司获批同意注射用HLX43联合HLX07及斯鲁利单抗注射液用于晚期实体瘤治疗开展临床试验。截至2025年12月，公司及控股子公司现阶段针对该治疗方案的累计研发投入约为266万元。截至本公告日期，全球范围内尚无同类联合用药治疗方案获批上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601273632288439.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000306685.HKD","02196","HK0000165453.HKD","BK1161","BK0012","BK0196","BK0175","BK1593","BK1191","BK0188","BK0060","HK0000320223.HKD","BK0183","BK0187","HK0000306701.USD","BK0028","BK1515","BK0096","HK0000320264.USD","02696","BK0239","600196"],"gpt_icon":0},{"id":"2606798796","title":"每日卖空追踪 | 复宏汉霖 01月27日卖空量成交10.45万股，卖空比例为3.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606798796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606798796?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:30","pubTimestamp":1769502636,"startTime":"0","endTime":"0","summary":"复宏汉霖北京时间01月27日，跌3.45%，卖空量成交10.45万股，较上一交易日增加808.7%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164136a6b23885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127164136a6b23885&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","HK0000306685.HKD","HK0000320264.USD","HK0000306701.USD","02696","BK1161","HK0000320223.HKD"],"gpt_icon":0},{"id":"2606213798","title":"复宏汉霖01月27日遭主力抛售2675.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606213798","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606213798?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:15","pubTimestamp":1769501717,"startTime":"0","endTime":"0","summary":"01月27日, 复宏汉霖股价跌3.45%，报收54.60元，成交金额1.5亿元，换手率1.66%，振幅4.33%，量比3.70。复宏汉霖今日主力资金净流出2675.8万元，上一交易日主力净流出501.8万元。该股近5个交易日下跌14.42%，主力资金累计净流出3488.9万元；近20日主力资金累计净流出2718.2万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127161617a6b21c5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127161617a6b21c5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","HK0000320223.HKD","02696","HK0000306685.HKD","HK0000165453.HKD","HK0000320264.USD","HK0000306701.USD"],"gpt_icon":0},{"id":"2605110936","title":"继鼻咽癌后瞄准食管鳞癌二线治疗 百利天恒双抗ADC第二项上市申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2605110936","media":"每经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605110936?lang=zh_cn&edition=full","pubTime":"2026-01-20 20:19","pubTimestamp":1768911590,"startTime":"0","endTime":"0","summary":"1月20日，CDE官网披露，百利天恒旗下核心管线iza-bren的第二项上市申请获得受理。食管鳞癌的后线治疗是临床上面临的主要挑战。2025年11月，鼻咽癌适应证的新药上市申请获CDE受理，有望在2026年率先实现商业化。肺癌、乳腺癌等适应证预计将于2026年开始递交新药上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012020200997a2989d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012020200997a2989d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1161","HK0000320264.USD","91194","02615","02696","HK0000306701.USD","HK0000306685.HKD","HK0000320223.HKD"],"gpt_icon":0},{"id":"2604195516","title":"复宏汉霖(02696)：HLX701联合西妥昔单抗和化疗治疗晚期结直肠癌的1b/2期临床试验申请获NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2604195516","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604195516?lang=zh_cn&edition=full","pubTime":"2026-01-20 17:00","pubTimestamp":1768899619,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复宏汉霖 公布，近日，HLX701联合西妥昔单抗和化疗治疗晚期结直肠癌的 1b/2期临床试验申请获国家药品监督管理局批准。HLX701是公司自FBD Biologics Limited许可引进的SIRPα-Fc融合蛋白，拟用于多种晚期实体瘤的治疗，目前该产品的多项1/2期临床试验正于全球范围内开展中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000320264.USD","HK0000306701.USD","02696","HK0000165453.HKD","HK0000306685.HKD","BK1161","HK0000320223.HKD"],"gpt_icon":0},{"id":"2605932110","title":"每日卖空追踪 | 复宏汉霖 01月20日卖空量成交1.77万股，卖空比例为2.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605932110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605932110?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:30","pubTimestamp":1768897833,"startTime":"0","endTime":"0","summary":"复宏汉霖北京时间01月20日，跌5.4%，卖空量成交1.77万股，较上一交易日增加210.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165334a4404a98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165334a4404a98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000306701.USD","HK0000320264.USD","02696","BK1161","HK0000320223.HKD","HK0000306685.HKD","HK0000165453.HKD"],"gpt_icon":0},{"id":"2604131565","title":"复宏汉霖(02696):联交所就公司H股全流通授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2604131565","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604131565?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:34","pubTimestamp":1768833269,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复宏汉霖(02696)发布公告，公司已收到联交所授出日期为2026年1月19日就182,645,856股H股(即将予转换及上市的非上市股的总数)上市及买卖的批准。转换及上市将涉及合计持有182,645,856股非上市股的17位参与股东，该等参与股东所持转换H股数目占公司于本公告日期已发行股份总数约33.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"复宏汉霖(02696):联交所就公司H股全流通授出上市批准","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000165453.HKD","HK0000306701.USD","HK0000320223.HKD","02696","HK0000306685.HKD","BK1161","HK0000320264.USD"],"gpt_icon":0},{"id":"2604792075","title":"复宏汉霖：中国证监会就本公司H股全流通出具备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2604792075","media":"新浪港股","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604792075?lang=zh_cn&edition=full","pubTime":"2026-01-18 17:02","pubTimestamp":1768726920,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　复宏汉霖（02696）发布公告，本公司已于近日接获中国证监会出具的《关于上海复宏汉霖生物技术股份有限公司境内未上市股份“全流通”备案通知书》（备案通知书）。根据备案通知书，本公司就本公司若干股东所持合计1.83亿股非上市股实施H股全流通向中国证监会的备案已完成。若本公司自备案通知书出具之日起12个月内未完成本次H股全流通转换及上市，拟继续推进的，应当向中国证监会更新备案材料。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-18/doc-inhhtphv7644011.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02696","HK0000165453.HKD","HK0000306701.USD","HK0000320264.USD","HK0000320223.HKD","HK0000306685.HKD"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0239},{"period":"1month","weight":-0.0384},{"period":"3month","weight":-0.0236},{"period":"6month","weight":-0.1906},{"period":"1year","weight":2.384},{"period":"ytd","weight":0.0535}],"compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.019},{"period":"3month","weight":0.0136},{"period":"6month","weight":0.08},{"period":"1year","weight":0.2914},{"period":"ytd","weight":0.0475}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海复宏汉霖生物技术股份有限公司是一家主要从事生物制药研发、生物制药服务及生物制药生产与销售的中国公司。该公司的主要产品包括汉曲优（注射用曲妥珠单抗）、汉奈佳（马来酸奈拉替尼片）、汉斯状（斯鲁利单抗注射液）、汉利康（利妥昔单抗注射液）、汉达远（阿达木单抗注射液）、汉贝泰（贝伐珠单抗注射液）等。该公司的产品主要应用于乳腺癌辅助治疗、转移性乳腺癌及转移性胃癌治疗、转移性非鳞状非小细胞肺癌、多关节型幼年特发性关节炎治疗等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.044394},{"month":2,"riseRate":0.714286,"avgChangeRate":0.100367},{"month":3,"riseRate":0.5,"avgChangeRate":-0.016995},{"month":4,"riseRate":0.833333,"avgChangeRate":0.128587},{"month":5,"riseRate":0.5,"avgChangeRate":-0.024483},{"month":6,"riseRate":0.666667,"avgChangeRate":0.109389},{"month":7,"riseRate":0.5,"avgChangeRate":0.069459},{"month":8,"riseRate":0.5,"avgChangeRate":-0.024213},{"month":9,"riseRate":0,"avgChangeRate":-0.127435},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.025526},{"month":11,"riseRate":0.571429,"avgChangeRate":0.058675},{"month":12,"riseRate":0.714286,"avgChangeRate":-0.023816}],"exchange":"SEHK","name":"复宏汉霖","nameEN":"HENLIUS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"复宏汉霖(02696)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供复宏汉霖(02696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"复宏汉霖,02696,复宏汉霖股票,复宏汉霖股票老虎,复宏汉霖股票老虎国际,复宏汉霖行情,复宏汉霖股票行情,复宏汉霖股价,复宏汉霖股市,复宏汉霖股票价格,复宏汉霖股票交易,复宏汉霖股票购买,复宏汉霖股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"复宏汉霖(02696)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供复宏汉霖(02696)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}